pennystocktracker
08-31-2009, 04:33 PM
WOW……. Delcath Systems, Inc (NASDAQ:DCTH) jumped over 30.6% in the early trading hour and currently trades at $3.97 on 2.38 million shares. Today (August 31, 2009), Delcath Systems, Inc announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. ……….
You can also check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!
You can also check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!